← Eichor
Condition: Gene Abnormality Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Gene Abnormality

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
Phase N/A · 2 location(s) · Number 2 Children's Hospital, Ho Chi Minh City · NCT06278428
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
Phase 2 · 25 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06496490
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Phase N/A · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT05959720
iCAGES-guided Precision Therapy for Cancers in Contrast to Standard Care or IHC-guided Theray
Phase N/A · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT03192501
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05735717
A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)
NA · 1 location(s) · Vasileios Kalles · NCT07292246
Genome Medical Sequencing for Gene Discovery
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT01087320
International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV)
Phase N/A · 15 location(s) · Translational Research Center for Medical Innovation, Kobe, · NCT02918032
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
Phase 2 · 2 location(s) · Murdoch Childrens Research Institute · NCT05983159
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumo
Phase 2 · 181 location(s) · American Society of Clinical Oncology · NCT02693535
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT04263935
Spermatogonial Differentiation Via Testicular Organoid
Phase 1/Phase 2 · 1 location(s) · CellARTs Inc. · NCT06841861
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.